A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

ClinicalTrials.gov ID: NCT07415031

Public ClinicalTrials.gov record NCT07415031. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 18, 2026, 4:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Solid Tumor Study for Long Term Treatment of Cancer Patients Who Have Participated in BMS Parent Studies Investigating Adagrasib (BMS-986503)

Study identification

NCT ID: NCT07415031
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Mirati Therapeutics Inc.; Industry
Enrollment: 170 participants

Conditions and interventions

Conditions

Solid Tumors

Interventions

Adagrasib Drug
Cetuximab Drug
Docetaxel Drug
Fluorouracil Drug
Irinotecan Drug
Leucovorin Drug
Oxaliplatin Drug
Pembrolizumab Drug
Pemetrexed Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: May 5, 2026
Primary completion: Feb 15, 2028
Completion: Feb 15, 2028
Last update posted: May 14, 2026

2026 – 2028

United States locations

U.S. sites: 17
U.S. states: 14
U.S. cities: 16

Facility	City	State	ZIP	Site status
Local Institution - 0005	Phoenix	Arizona	85054	Withdrawn
Local Institution - 0016	Bellflower	California	90706	Not yet recruiting
Local Institution - 0082	Long Beach	California	90806	Not yet recruiting
Local Institution - 0003	Newark	Delaware	19713	Withdrawn
Local Institution - 0001	St. Petersburg	Florida	33701	Not yet recruiting
Local Institution - 0064	Chicago	Illinois	60637	Not yet recruiting
Local Institution - 0112	Wichita	Kansas	67208	Not yet recruiting
Local Institution - 0092	Boston	Massachusetts	00215	Not yet recruiting
Local Institution - 0080	Boston	Massachusetts	02215	Not yet recruiting
Mayo Clinic in Rochester, Minnesota	Rochester	Minnesota	55905	Recruiting
Local Institution - 0073	Saint Paul	Minnesota	55101	Not yet recruiting
Local Institution - 0036	Omaha	Nebraska	68114	Not yet recruiting
Local Institution - 0116	New York	New York	10065 6800	Not yet recruiting
Local Institution - 0004	Eugene	Oregon	97401	Not yet recruiting
Local Institution - 0023	Germantown	Tennessee	38138	Not yet recruiting
Local Institution - 0002	Grapevine	Texas	76051	Not yet recruiting
Local Institution - 0013	Bellingham	Washington	98225	Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 60 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07415031, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 14, 2026 · Synced May 18, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07415031 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →